Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment
Cardiac magnetic resonance (CMR) allows for analysis of cardiac function and myocardial tissue characterization. Increased left ventricular mass (LVM) is an independent predictor of cardiovascular events; however, the diagnosis of left ventricular hypertrophy and its prognostic value strongly depend...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/2/178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588704160415744 |
|---|---|
| author | Patrycja S. Matusik Katarzyna Mikrut Amira Bryll Tadeusz J. Popiela Paweł T. Matusik |
| author_facet | Patrycja S. Matusik Katarzyna Mikrut Amira Bryll Tadeusz J. Popiela Paweł T. Matusik |
| author_sort | Patrycja S. Matusik |
| collection | DOAJ |
| description | Cardiac magnetic resonance (CMR) allows for analysis of cardiac function and myocardial tissue characterization. Increased left ventricular mass (LVM) is an independent predictor of cardiovascular events; however, the diagnosis of left ventricular hypertrophy and its prognostic value strongly depend on the LVM indexation method. Evaluation of the quantity and distribution of late gadolinium enhancement assists in clinical decisions on diagnosis, cardiovascular assessment, and interventions, including the placement of cardiac implantable electronic devices and the choice of an optimal procedural approach. Novel CMR techniques, such as T1 and T2 mapping, may be used for the longitudinal follow-up of myocardial fibrosis and myocardial edema or inflammation in different groups of patients, including patients with systemic sclerosis, myocarditis, cardiac sarcoidosis, amyloidosis, and both ischemic and non-ischemic cardiomyopathy, among others. Moreover, CMR tagging and feature tracking techniques might improve cardiovascular risk stratification in patients with different etiologies of left ventricular dysfunction. This review summarizes the knowledge about the current role of CMR in diagnostics and cardiovascular risk assessment to enable more personalized approach in clinical decision making. |
| format | Article |
| id | doaj-art-7471fe9eddbb4816b911b6c99d70192f |
| institution | Kabale University |
| issn | 2075-4418 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj-art-7471fe9eddbb4816b911b6c99d70192f2025-01-24T13:29:00ZengMDPI AGDiagnostics2075-44182025-01-0115217810.3390/diagnostics15020178Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk AssessmentPatrycja S. Matusik0Katarzyna Mikrut1Amira Bryll2Tadeusz J. Popiela3Paweł T. Matusik4Department of Radiology, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Kraków, PolandDepartment of Cardiology, Advocate Lutheran General Hospital, Park Ridge, IL 60068, USADepartment of Radiology, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Kraków, PolandDepartment of Radiology, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Kraków, PolandDepartment of Electrocardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Kraków, PolandCardiac magnetic resonance (CMR) allows for analysis of cardiac function and myocardial tissue characterization. Increased left ventricular mass (LVM) is an independent predictor of cardiovascular events; however, the diagnosis of left ventricular hypertrophy and its prognostic value strongly depend on the LVM indexation method. Evaluation of the quantity and distribution of late gadolinium enhancement assists in clinical decisions on diagnosis, cardiovascular assessment, and interventions, including the placement of cardiac implantable electronic devices and the choice of an optimal procedural approach. Novel CMR techniques, such as T1 and T2 mapping, may be used for the longitudinal follow-up of myocardial fibrosis and myocardial edema or inflammation in different groups of patients, including patients with systemic sclerosis, myocarditis, cardiac sarcoidosis, amyloidosis, and both ischemic and non-ischemic cardiomyopathy, among others. Moreover, CMR tagging and feature tracking techniques might improve cardiovascular risk stratification in patients with different etiologies of left ventricular dysfunction. This review summarizes the knowledge about the current role of CMR in diagnostics and cardiovascular risk assessment to enable more personalized approach in clinical decision making.https://www.mdpi.com/2075-4418/15/2/178cardiac magnetic resonanceCMRcardiovascular risk stratificationLVM indexingLGEnovel techniques |
| spellingShingle | Patrycja S. Matusik Katarzyna Mikrut Amira Bryll Tadeusz J. Popiela Paweł T. Matusik Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment Diagnostics cardiac magnetic resonance CMR cardiovascular risk stratification LVM indexing LGE novel techniques |
| title | Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment |
| title_full | Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment |
| title_fullStr | Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment |
| title_full_unstemmed | Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment |
| title_short | Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment |
| title_sort | cardiac magnetic resonance imaging in diagnostics and cardiovascular risk assessment |
| topic | cardiac magnetic resonance CMR cardiovascular risk stratification LVM indexing LGE novel techniques |
| url | https://www.mdpi.com/2075-4418/15/2/178 |
| work_keys_str_mv | AT patrycjasmatusik cardiacmagneticresonanceimagingindiagnosticsandcardiovascularriskassessment AT katarzynamikrut cardiacmagneticresonanceimagingindiagnosticsandcardiovascularriskassessment AT amirabryll cardiacmagneticresonanceimagingindiagnosticsandcardiovascularriskassessment AT tadeuszjpopiela cardiacmagneticresonanceimagingindiagnosticsandcardiovascularriskassessment AT pawełtmatusik cardiacmagneticresonanceimagingindiagnosticsandcardiovascularriskassessment |